SIMPLEX TRADING, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 207 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$209
+74.2%
5,485
+64.3%
0.00%
Q2 2023$120
-99.9%
3,339
-12.8%
0.00%
Q3 2022$151,0003,831
-65.7%
0.00%
Q1 2021$0
-100.0%
11,159
+1323.3%
0.00%
Q4 2020$33,000
-96.2%
784
-97.6%
0.00%
-100.0%
Q3 2020$870,000
+383.3%
33,127
+230.2%
0.00%
Q1 2020$180,000
+16.1%
10,032
+10.6%
0.00%
Q2 2019$155,000
+1.3%
9,071
-5.1%
0.00%
Q1 2019$153,000
+11.7%
9,562
+1.7%
0.00%
Q4 2018$137,000
-42.4%
9,406
-28.4%
0.00%
-100.0%
Q3 2018$238,000
+83.1%
13,135
+70.2%
0.00%0.0%
Q2 2018$130,000
+5.7%
7,717
+22.0%
0.00%
-80.0%
Q1 2018$123,000
-45.1%
6,325
-42.9%
0.01%
-50.0%
Q4 2017$224,000
+194.7%
11,077
+151.5%
0.01%
+233.3%
Q3 2017$76,000
+300.0%
4,404
+193.6%
0.00%
+200.0%
Q1 2017$19,000
+375.0%
1,500
+385.4%
0.00%
Q3 2015$4,000
-98.7%
309
-97.8%
0.00%
-100.0%
Q2 2015$314,000
+613.6%
13,933
+350.6%
0.03%
+420.0%
Q1 2015$44,0003,0920.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders